DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Ketanserin is an investigational drug.
There have been 9 clinical trials for Ketanserin. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Foot Ulcer, Diabetic Foot, and Shock, Septic. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Gitte Moos Knudsen, and Psychiatric University Hospital, Zurich.
Recent Clinical Trials for Ketanserin
|Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness||University Hospital, Basel, Switzerland||Phase 1|
|Effect of Ketanserin After LSD Administration||University Hospital, Basel, Switzerland||Phase 1|
|Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)||Matthias Liechti||Early Phase 1|